Celsion posts Q2 loss of $0.19/share
Celsion Corp: Celsion Corporation reports second quarter 2016 financial results and provides business update . Q2 loss per share $0.19 .Q2 earnings per share view $-0.21 -- Thomson Reuters I/B/E/S.
Latest Key Developments inBiotechnology
- Nucana Announces Promising Clinical Data On Nuc-1031 As Front-Line Treatment Of Advanced Biliary Tract Cancer
- Orexigen Therapeutics Says Expect Annualized Savings Associated With Feb 2018 Reduction In Sales Force Of About $30 Mln
- Albireo Pharma Says Elobixibat Approved In Japan For Treatment Of Chronic Constipation
- Bradley Thomas Sorenson Reports 5.6 Pct Stake In Arcturus Therapeutics As Of Nov. 16, 2017